证券代码：300082 证券简称：奥克股份 编号：2020-001 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|-------------------------------------|---------------------------------------------| | | | | | 投资者关系活动 | □ 特定对象调研 □分析师会议 | | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | ☑ 其他 公司 20 20 | 年中期业绩说明会 | | 参与单位名称及 | 国金证券股份有限公司 杨翼荥、孙昊昱 | | | 人员姓名 | | 广发证券股份有限公司 李洲、黄璐叶丹、何雄 | | | 光大证券股份有限公司 傅锴铭 | | | | 中信证券股份有限公司 王喆 | | | | 长城证券股份有限公司 | 濮阳 | | | 东方证券股份有限公司 倪吉 | | | | 西部证券股份有限公司 陈默 | | | | 中信建投证券股份有限公司 郑 ...

证券代码：300082 证券简称：奥克股份 编号：2018-001 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------- ...

编号：2020-002 证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |----------------|------------------------------------------|--------------| | | | | | 投资者关系活动 | ☑ 特定对象调研 □分析师会议 | | | 类别 | □ 媒体采访 □业绩说明会 | | | | □ 新闻发布会 □路演活动 | | | | ☑ 现场参观 | | | | □ 其他 | | | | 招商证券股份有限公司 | 游家训 | | | 光大证券股份有限公司 傅锴铭 | | | | 中信证券股份有限公司 | 王喆、王凯旋 | | | 东方证券股份有限公司 | 倪吉 | | | 国盛证券有限责任公司 杨义韬 | | | 参与单位名称及 | 太平洋证券股份有限公司 柳强 | | | 人员姓名 | 方正证券股份有限公司 赵小燕 | | | | 中国国际金融股份有限公司 | 吴頔 | | | 南方基金管理股份有限公司 都逸敏 | | | | 中大君悦投资有限公司 | 陈 ...

编号：2021-001 投资者关系活动 □特定对象调研 □分析师会议 类别 □媒体采访 ☑业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------------------------|----------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300082 证券简称：奥克股份 辽宁奥克化学股份有限公司 投资者关系活动记录表 编号：2022 -001 | --- | --- | --- | --- | --- | --- | --- | |-------------------------------------|--------------------------------------------------------------------------------------------------------------|--------------|--------------------------------------------------------|-------|-------|-------| | | | | | | | | | 投资者关系活动类别 | ☐ 特定对象调研 | ☐ 分析师会议 | | | | | | | ☐ 媒体采访 | 业绩说明会 | | | | | | | ☐ 新闻发布会 | ☐ 路演活动 | | | | | | | ☐ 现场参观 | | | | | | | | ☐其他（请文字说明其他活动内容） ...

Financial Performance - The company's revenue for Q3 2022 was ¥1,455,373,355.79, a decrease of 22.24% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of ¥38,984,070.94, down 135.48% year-on-year[4]. - The basic earnings per share were -¥0.06, reflecting a decline of 137.50% compared to the previous year[4]. - The total operating revenue for the third quarter of 2022 was CNY 4,374,107,334.73, a decrease of 12.3% compared to CNY 4,988,041,923.23 in the same period last year[24]. - The net profit for the third quarter of 2022 was CNY 16,885,335.32, down 91.9% from CNY 208,367,050.25 in the previous year[25]. - The basic earnings per share for the third quarter was CNY 0.01, down from CNY 0.28 in the same period last year, indicating a significant decline in profitability[26]. Assets and Liabilities - Total assets at the end of the reporting period were ¥6,151,350,652.98, a decrease of 9.05% from the end of the previous year[4]. - The company's total assets decreased to CNY 6,151,350,652.98 from CNY 6,763,326,789.61, reflecting a decline of 9.1%[23]. - The total liabilities decreased to CNY 2,661,354,407.20 from CNY 3,059,835,688.71, a reduction of 13.0%[23]. - The total current assets decreased from 3,274,865,984.51 CNY at the beginning of the year to 2,377,796,497.27 CNY by September 30, 2022[21]. - The total non-current assets increased to CNY 3,773,554,155.71 from CNY 3,488,460,805.10, reflecting a growth of 8.2%[23]. Cash Flow - The company reported a cash flow from operating activities of ¥121,388,900.00, which decreased by 1.60% year-to-date[4]. - The company's cash flow from operating activities showed a significant decline, impacting liquidity and operational flexibility[26]. - The net cash flow from operating activities for the current period is ¥121,388,900, a slight decrease from ¥123,363,062 in the previous period[27]. - Cash inflow from investment activities totaled ¥1,592,250,840.88, up from ¥1,223,084,240.63 in the previous period[28]. - The net cash flow from investment activities is -¥280,782,999.91, an improvement from -¥388,330,204.15 in the previous period[28]. - The net cash flow from financing activities decreased by 163.07% year-to-date, primarily due to a reduced increase in bank borrowings[12]. - The net cash flow from financing activities is -¥86,538,669.01, a decline from ¥137,202,518.84 in the previous period[28]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 41,583[14]. - The largest shareholder, Aoke Holdings Group, holds 52.89% of shares, totaling 359,698,573 shares, with 44,380,000 shares pledged[14]. - The top ten shareholders do not have any known relationships or agreements among them[15]. - The company has no preferred shareholders as of the reporting period[16]. Operational Changes - The company experienced a 51.37% decrease in notes receivable compared to the beginning of the year, primarily due to a reduction in discounted notes[9]. - The construction in progress increased by 128.44% year-to-date, mainly due to investments in new projects[9]. - Research and development expenses increased to CNY 42,461,480.37, up 16.5% from CNY 36,535,237.57 in the previous year, indicating a focus on innovation[24]. - The company is focusing on market expansion and new product development as part of its strategic initiatives for future growth[26]. Legal Matters - The company is involved in a lawsuit regarding a compensation claim of 175,745,194.98 CNY against Chen Yegang, with hearings held in June and August 2022[19]. - The company has submitted listing guidance materials for its associate, Wuhan Jihua Chang New Materials Co., Ltd., to the Hubei Securities Regulatory Bureau[19].

Financial Performance - The company's operating revenue for the first half of 2022 was ¥2,918,733,978.94, a decrease of 6.35% compared to ¥3,116,538,221.72 in the same period last year[20]. - The net profit attributable to shareholders was ¥47,772,219.73, down 42.76% from ¥83,465,458.98 year-on-year[20]. - The net profit after deducting non-recurring gains and losses was ¥35,377,898.72, reflecting a decline of 49.27% compared to ¥69,739,978.21 in the previous year[20]. - The net cash flow from operating activities was ¥43,252,569.17, a significant drop of 76.31% from ¥182,606,860.56 in the same period last year[20]. - Basic earnings per share decreased to ¥0.07, down 41.67% from ¥0.12 in the previous year[20]. - Total assets at the end of the reporting period were ¥6,588,170,583.77, a decrease of 2.59% from ¥6,763,326,789.61 at the end of the previous year[20]. - The net assets attributable to shareholders decreased by 4.74% to ¥3,285,951,823.60 from ¥3,449,480,545.49 at the end of the previous year[20]. - The weighted average return on net assets was 1.42%, down 1.18 percentage points from 2.60% in the previous year[20]. - The company's revenue for the reporting period was approximately ¥2.92 billion, a decrease of 6.35% compared to ¥3.12 billion in the same period last year[44]. - The company's operating costs were approximately ¥2.73 billion, down 5.99% from ¥2.90 billion year-on-year[44]. Investment and R&D - Research and development investment amounted to approximately ¥88.07 million, a decrease of 9.23% compared to ¥97.02 million in the previous year[44]. - The company holds 111 authorized invention patents and 140 utility model patents, with 34 new patents granted in the first half of 2022[39]. - The company is focusing on technological innovation and strategic partnerships to enhance its product offerings and market position[80]. - New product development efforts are focused on enhancing chemical production efficiency, with an investment of 14.9 million planned for R&D in 2022[140]. Market and Sales - The company has a production capacity of 300,000 tons of ethylene oxide and a strategic layout of 1.6 million tons of ethoxylation capacity across various regions[28]. - The company is a leading producer of polycarboxylate superplasticizers and has established a complete industrial chain from ethylene to ethylene oxide and its derivatives[28]. - The company expects continuous growth in the sales scale of electrolyte solvents, driven by the rapid development of lithium-ion batteries in electric vehicles[30]. - In the first half of 2022, the sales volume of polycarboxylate superplasticizer decreased by 6.97% year-on-year, and the gross margin declined by 3.51%[33]. - The sales volume of pharmaceutical polyethylene glycol excipients increased by 50.37% year-on-year during the reporting period[35]. Financial Position and Cash Flow - The company's cash and cash equivalents increased to ¥629,712,902.22, representing 9.56% of total assets, up from 9.14% at the end of the previous year[51]. - Inventory rose significantly to ¥595,955,554.93, which is 9.05% of total assets, reflecting an increase in finished goods[51]. - The gross margin for polyethylene glycol was 21.63%, with revenue of ¥193,561,314.04, reflecting a year-on-year increase of 53.34%[47]. - The company reported a significant increase in sales expenses by 48.67% due to increased inventory and storage costs[44]. - The net cash flow from operating activities decreased by 76.31% to approximately ¥43.25 million, primarily due to increased inventory levels[44]. Environmental and Regulatory Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[93]. - The company reported a total COD discharge of 3.32 tons for the period, with no exceedance of discharge standards[93]. - The company has established various environmental protection facilities, including wastewater collection pools and online monitoring systems, which are all operating normally[98]. - The company has implemented a comprehensive environmental monitoring plan to manage potential pollution risks[100]. - The company’s wastewater treatment facilities across subsidiaries are functioning effectively, ensuring compliance with environmental standards[98]. Strategic Partnerships and Expansion - The company has established international platforms in Indonesia and Singapore to support its international development strategy[29]. - The company has established a strategic partnership with major clients such as Lvyang, Dongfang Yuhong, and Sika, enhancing its market competitiveness[40]. - The company is exploring market expansion opportunities in Southeast Asia, targeting a 15% market share by the end of 2023[140]. - The company is actively pursuing talent planning in line with its business strategy to enhance operational efficiency and competitiveness[38]. Legal and Compliance Issues - The company is currently involved in a contract dispute with a claim amount of CNY 2,734 million, which is still in the execution process[123]. - The company has reported a significant litigation case involving a performance commitment compensation and equity impairment compensation amounting to CNY 17,574.52 million[123]. - The average burden of the company in the ongoing litigation is expected to be significant, with multiple claims in process[124]. - The company has strengthened its collection efforts for accounts receivable and overdue payments during the reporting period[123]. Corporate Governance - The company did not distribute cash dividends or issue bonus shares for the half-year period[89]. - The company held its annual general meeting on May 20, 2022, with a participation rate of 57.80%[87]. - The company has no stock incentive plans or employee stock ownership plans in place during the reporting period[90]. - The company has committed to avoiding any substantial competition with its controlled subsidiaries and affiliates, ensuring no direct or indirect engagement in competing activities[116].

Financial Performance - The company's operating revenue for 2021 was ¥6,717,428,323.07, representing a 17.67% increase compared to ¥5,708,496,215.32 in 2020[20]. - The net profit attributable to shareholders for 2021 was ¥352,237,905.21, a decrease of 12.54% from ¥402,726,079.80 in 2020[20]. - The net cash flow from operating activities decreased by 20.23% to ¥496,827,950.63 in 2021, down from ¥622,849,757.51 in 2020[20]. - The total assets at the end of 2021 were ¥6,763,326,789.61, an increase of 24.48% from ¥5,433,135,137.77 at the end of 2020[20]. - The net assets attributable to shareholders increased by 5.16% to ¥3,449,480,545.49 at the end of 2021, compared to ¥3,280,376,280.91 at the end of 2020[20]. - The basic earnings per share for 2021 were ¥0.52, down 11.86% from ¥0.59 in 2020[20]. - The weighted average return on equity decreased by 1.50 percentage points to 10.63% in 2021, compared to 12.13% in 2020[20]. - The net profit after deducting non-recurring gains and losses was ¥337,566,539.11 in 2021, a decrease of 9.94% from ¥374,815,569.32 in 2020[20]. - The company achieved a revenue of 671,742.83 million CNY in 2021, representing a year-on-year growth of 17.67%[59]. - The concrete admixture industry accounted for 82.36% of total revenue, with revenue of ¥5,532,793,673.04, up 20.89% from the previous year[67]. - The polyethylene glycol segment saw a significant revenue increase of 182.17%, reaching ¥311,663,355.65, compared to ¥110,450,613.10 in 2020[69]. Cash Flow and Investments - The net cash flow from operating activities decreased by 20.23% to ¥496,827,950.63, primarily due to a decline in net profit and increased working capital requirements[86]. - The company reported a net cash outflow from investment activities of ¥637,329,126.65, a 71.34% increase compared to the previous year, mainly due to increased cash outflows for long-term assets[87]. - Cash flow from financing activities increased by 251.18% to ¥144,237,705.97, driven by an increase in bank loans compared to the previous year[86]. - The company has ongoing significant non-equity investments, including a project for a 100,000-ton/year ethylene oxide production facility, with an actual investment of CNY 71,517,169[108]. - The company reported a cumulative investment of CNY 142,822,903 in the 100,000-ton/year ethylene oxide project, achieving 100% of the planned progress[108]. Market and Product Development - The company is expanding its market presence in the pharmaceutical excipients sector, supplying over 400 formulation enterprises in China[34]. - The company is focusing on developing narrow distribution polyethylene oxide for lithium battery applications, which is expected to broaden its product range and mitigate competition risks[82]. - The company aims to enhance its core technology development and application transformation, focusing on high-quality development and sustainable practices[125]. - The company plans to strengthen its position in the epoxy-derived fine chemical industry by expanding its product range and investing in high-end electronic chemicals and energy battery materials[130]. - The company is actively involved in the research and development of fine chemical new materials, particularly in the field of epoxy derivatives[150]. Environmental and Sustainability Initiatives - The company is committed to sustainable development, focusing on green and biodegradable products that align with national policies on green and concentrated production[36]. - The company is committed to safety and environmental protection, ensuring that production facilities meet high standards to mitigate risks associated with hazardous chemicals[133]. - The company has implemented advanced treatment technologies to ensure compliance with the stringent environmental standards for wastewater discharge[200]. - The total annual discharge of pollutants was reported at 4.687 tons, reflecting the company's commitment to reducing environmental impact[200]. - The company is exploring potential mergers and acquisitions to strengthen its market position and enhance operational efficiencies[200]. Governance and Management - The company has established an independent financial accounting department, with its own financial personnel and management systems, ensuring financial independence[143]. - The company’s board of directors and supervisory board operate independently, with no subordinate relationship to the controlling shareholder[143]. - The company has a well-defined governance structure, ensuring independence in operations and decision-making[143]. - The company has a total of 98 authorized invention patents and over 100 utility model patents as of the end of 2021, with 37 new patents granted and 46 new applications filed during the year[55]. - The company has established a comprehensive talent development system focusing on management, technical expertise, and operational skills to enhance its workforce[53]. Future Outlook and Strategic Plans - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% based on new product launches and market expansion strategies[167]. - The company plans to enhance its digital marketing strategy, increasing the budget by 30% to boost online sales channels[164]. - The company is investing in new technology, allocating 50 million RMB for R&D to improve production efficiency by 15%[164]. - The company aims to enhance market share and improve the value contribution of high-margin products through differentiated marketing and product structure adjustments[128]. - The company plans to increase R&D investment and strengthen collaboration with academic institutions to enhance technological contributions and optimize product structure[126].

辽宁奥克化学股份有限公司 2022 年第一季度报告 证券代码：300082 证券简称：奥克股份 公告编号：2022-022 辽宁奥克化学股份有限公司 2022年第一季度报告 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）声明：保证季度报告中财务 信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 1,339,641,333.20 | 1,381,921,145.23 | -3.06% | | 归属于上市公司股东的净利润（元） | 99,723,888.74 | 51,120,12 ...

Financial Performance - The company's operating revenue for Q3 2021 was CNY 1,871.50 million, an increase of 20.19% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was CNY 109.88 million, a decrease of 33.04% year-on-year[3]. - The company's basic earnings per share for Q3 2021 was CNY 0.16, down 33.33% from the previous year[3]. - The net profit for the third quarter of 2021 was CNY 208,367,050.25, a decrease of 37% from CNY 330,818,664.01 in the previous year[27]. - The net profit attributable to the parent company was CNY 193,348,107.42, compared to CNY 305,532,524.43 in the previous period, representing a decrease of approximately 36.7%[28]. - The total comprehensive income attributable to the parent company was CNY 193,354,332.54, down from CNY 305,351,008.08, indicating a decline of about 36.5%[28]. - Basic and diluted earnings per share were both CNY 0.28, down from CNY 0.45 in the previous period, indicating a decrease of about 37.8%[28]. Cash Flow - The net cash flow from operating activities decreased by 74.07% year-to-date, amounting to CNY 123.36 million[10]. - The net cash flow from operating activities was CNY 123,363,062.69, significantly lower than CNY 475,813,877.23 in the previous period, reflecting a decrease of approximately 74.1%[30]. - The cash flow from investment activities showed a net outflow of CNY 388,330,204.15, compared to a net outflow of CNY 289,156,536.64 in the previous period[31]. - Cash flow from financing activities generated a net inflow of CNY 137,202,518.84, contrasting with a net outflow of CNY 265,557,486.46 in the previous period[31]. - The company received CNY 28,049,068.08 in tax refunds, significantly higher than CNY 9,925,385.85 in the previous period, representing an increase of approximately 183.5%[30]. - The total cash and cash equivalents at the end of the period were CNY 366,042,886.27, up from CNY 261,576,904.53 in the previous period, marking an increase of approximately 39.9%[31]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,652.45 million, reflecting a 4.04% increase from the end of the previous year[3]. - The company's total assets as of September 30, 2021, were CNY 5,652,447,915.34, compared to CNY 5,433,135,137.77 at the end of 2020, representing a growth of 4%[24]. - The total current liabilities increased to CNY 2,075,880,630.90 from CNY 1,834,713,933.47, marking an increase of 13.2%[24]. - The company's total liabilities increased by 66.42% in short-term borrowings, amounting to CNY 519.03 million[7]. - The total liabilities as of September 30, 2021, were CNY 2,161,887,529.95, an increase from CNY 1,922,791,848.10, representing a growth of 12.4%[24]. Investments and Projects - The company plans to invest 1.05 billion RMB in the first phase of the carbon dioxide comprehensive utilization project in Chengdu New Materials Industry Functional Zone[18]. - The company plans to invest CNY 2.1 billion in the second phase of a project, with further agreements to be signed based on future developments[20]. - The company transferred 37% equity of Shanghai Dongshuo Environmental Technology Co., Ltd. for 59.49 million RMB, completing the transaction and changing the shareholder register[18]. - The company is actively expanding its market presence through strategic investments and partnerships[18]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 37,224, with the largest shareholder, Aoke Holdings Group Co., Ltd., holding 52.89% of shares[12]. - The top ten shareholders hold a significant portion of shares, with the largest shareholder having 359,698,573 shares, which is 52.89% of the total[12]. - The company reported a total of 2,422,924 restricted shares at the end of the period, with no shares released during the current period[17]. - The company has no preferred shareholders as indicated in the report[15]. Operational Metrics - The company reported a 37.67% increase in accounts receivable compared to the beginning of the year, totaling CNY 109.34 million[7]. - The total operating revenue for the third quarter of 2021 was CNY 4,988,041,923.23, an increase of 27.5% compared to CNY 3,911,819,077.00 in the same period last year[26]. - The total operating costs for the third quarter of 2021 were CNY 4,798,408,995.75, up from CNY 3,540,136,274.32, reflecting a year-over-year increase of 35.5%[26]. - Research and development expenses for the third quarter of 2021 were CNY 36,535,237.57, compared to CNY 33,742,368.70 in the previous year, reflecting an increase of 8.3%[27]. - The company's long-term equity investments were CNY 281,128,525.59, down from CNY 299,636,255.01, indicating a decrease of 6.2%[23]. - The cash and cash equivalents decreased to CNY 500,522,897.80 from CNY 638,548,420.13, a decline of 21.6%[22].